|
May 16
|
Merck to Present New Clinical and Outcomes Research Data at The American Thoracic Society’s (ATS) 2025 International Conference Demonstrating Commitment to Advancing Research in Pulmonary Arterial Hypertension
|
|
May 15
|
FDA awards cancer drug approvals to AbbVie and MSD
|
|
May 15
|
FDA approves Merck’s belzutifan for pheochromocytoma or paraganglioma
|
|
May 15
|
Jefferies not seeing significant impact to Merck, Bristol from draft guidance
|
|
May 15
|
Merck Announces Phase 3 KEYNOTE-B96 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Platinum-Resistant Recurrent Ovarian Cancer Whose Tumors Expressed PD-L1 and in All Comers
|
|
May 15
|
The Zacks Analyst Blog Highlights Oracle, IBM, Merck and Earth Science Tech
|
|
May 14
|
Top Analyst Reports for Oracle, IBM & Merck
|
|
May 14
|
FDA Approves Merck’s WELIREG® (belzutifan) for the Treatment of Adults and Pediatric Patients 12 Years and Older With Locally Advanced, Unresectable, or Metastatic Pheochromocytoma or Paraganglioma (PPGL)
|
|
May 14
|
FDA Approves Merck's Kidney Cancer Drug For Rare Type Of Neuroendocrine Tumors
|
|
May 14
|
Merck (NYSE:MRK) Showcases Broad Cancer Research Portfolio At ASCO Annual Meeting
|
|
May 13
|
Is Merck & Co. (MRK) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?
|
|
May 13
|
Research on Novel Treatment Approaches and Scientific Advances From Merck’s Broad and Differentiated Oncology Portfolio and Pipeline to be Presented at ASCO 2025
|
|
May 12
|
Trump's drug price order is part request, part threat: Analyst
|
|
May 12
|
How Trump could go about executing order to slash drug prices
|
|
May 12
|
Merck & Co., Inc. (MRK): One of the Worst Blue Chip Stocks to Buy
|
|
May 12
|
Drug wars: Wall Street says big questions remain about impact of Trump's new pricing order
|
|
May 12
|
Mag 7 rally, airline & pharmaceutical stocks: Trending Tickers
|
|
May 12
|
MRK Q1 Earnings Call: Pipeline Expansion, Tariff Pressures, and Portfolio Diversification
|
|
Apr 1
|
Top Analyst Reports for Amazon, Oracle & Merck
|
|
Apr 1
|
Merck to Hold First-Quarter 2025 Sales and Earnings Conference Call April 24
|